Computational Approaches in Cheminformatics and Bioinformatics

ISBN 10: 0470384417 / ISBN 13: 9780470384411

Verlag: Wiley, 2012

Beschreibung

Like New.

Bestandsnummer des Verkäufers ERICA77504703844176

Bibliografische Details

• Titel: Computational Approaches in Cheminformatics and Bioinformatics
• Verlag: Wiley
• Erscheinungsjahr: 2012
• Sprache: Englisch
• ISBN-10: 0470384417
• ISBN-13: 9780470384411
• Einband: Hardcover
• Zustand: Like New
• Buchtyp: book

Über diesen Titel

Inhaltsangabe

Computational Approaches in Cheminformatics and Bioinformatics explores for the first time the unique connection between cheminformatics and bioinformatics. This revolutionary resource demonstrates how integrating these two seemingly different disciplines allows one to computationally address discovery and identification of biological systems in relation to future development. Additionally, the book includes insights from experts from public (NIH), academic, and industrial sources (Novartis, Pfizer). Scientists will find this ground-breaking book essential to the advancement of drug discovery and the issue of chemical control and manipulation of such systems.

Über die Autorin bzw. den Autor

RAJARSHI GUHA , PhD, is a Research Scientist at the NIH Center for Translational Therapeutics in Rockville, Maryland. His research covers a variety of topics in cheminformatics and chemical data mining, addressing software and methodology development as well as applications in areas such as high throughput screening and high content imaging of small molecules and siRNA's. Prior to working at the NIH, he was a visiting assistant professor in the School of Informatics and Computing, Indiana University. ANDREAS BENDER , PhD, is a Lecturer for Molecular Informatics with the Unilever Centre for Molecular Science Informatics at the University of Cambridge. His research encompasses ways to integrate-and analyze-chemical, biological, and phenotypic data, with the aim to design molecular structures with a desired property profile. Andreas Bender received his PhD from the University of Cambridge and worked for the Novartis Institutes for Biomedical Research in Cambridge, Massachusetts before returning to his current position in academia.